Log in to save to my catalogue

LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption

LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1805506541

LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption

About this item

Full title

LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2016-05, Vol.22 (5), p.539-546

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

LGR4 has been identified as a new receptor for RANKL in bone cells where it opposes RANK signaling to inhibit osteoclasts differentiation, and its therapeutic targeting promotes reduced bone loss in three mouse models of osteoporosis.
Tumor necrosis factor (TNF) superfamily member 11 (TNFSF11, also known as RANKL) regulates multiple physiologica...

Alternative Titles

Full title

LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1805506541

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1805506541

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm.4076

How to access this item